Posted inBiotechnology
Posted inBiotechnology
Regeneron acquires UK biotech, adding Oxular’s eye disease delivery tech to portfolio
Regeneron has scooped up Oxular, a retinal-disease-focused company based in the U.K., closing the deal at the very end of…




















